Pergolide
Top View
- Jack Deruiter, Principles of Drug Action 2, Fall 2001
- Pergolide Mesylate Can Improve Sexual Dysfunction in Patients with Parkinson’S Disease: the Results of an Open, Prospective, 6-Month Follow-Up
- A Case of Constrictive Pericarditis During Cabergoline Treatment For
- Deep Learning Integration of Molecular and Interactome Data for Protein–Compound Interaction Prediction Narumi Watanabe, Yuuto Ohnuki and Yasubumi Sakakibara*
- Management of Parkinson's Disease During Periods of Fasting
- New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A
- TEACHERS' TOPICS Ergot and Its Alkaloids
- Rotigotine Patches (Neupro®) in the Treatment of Parkinson's Disease
- Chronic Pericardial Constriction Linked to the Antiparkinsonian Dopamine Agonist Pergolide K P Balachandran, D Stewart, G a Berg, K G Oldroyd
- PERGOLIDE (Veterinary—Systemic)
- HHS Public Access Author Manuscript
- Summary of Product Characteristics
- Recent Progress in Ergot Alkaloid Research†
- Australian Public Assessment Report for Rotigotine
- Cirrus® / Zyrtec-D® 5 Mg/120 Mg Tablets
- Use of Apomorphine in Parkinsonian with Neuropsychiatric
- MR Lee, MR Lee
- Apomorphine (APO-Go)